SrasV1, Ncbi, Merge, bibRecord, 003477

Host resilience to emerging coronaviruses.

Identifieur interne : 003477 ( Ncbi/Merge ); précédent : 003476; suivant : 003478

Host resilience to emerging coronaviruses.

Auteurs : Amanda M. Jamieson [États-Unis]

Source :

Future virology [ 1746-0794 ] ; 2016.

RBID : pubmed:32201496

Abstract

Recently, two coronaviruses, severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, have emerged to cause unusually severe respiratory disease in humans. Currently, there is a lack of effective antiviral treatment options or vaccine available. Given the severity of these outbreaks, and the possibility of additional zoonotic coronaviruses emerging in the near future, the exploration of different treatment strategies is necessary. Disease resilience is the ability of a given host to tolerate an infection, and to return to a state of health. This review focuses on exploring various host resilience mechanisms that could be exploited for treatment of severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome coronavirus and other respiratory viruses that cause acute lung injury and acute respiratory distress syndrome.

DOI: 10.2217/fvl-2016-0060
PubMed: 32201496

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000C32
to stream PubMed, to step Curation: 000C32
to stream PubMed, to step Checkpoint: 000C45

Links to Exploration step

pubmed:32201496

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Host resilience to emerging coronaviruses.</title>
<author><name sortKey="Jamieson, Amanda M" sort="Jamieson, Amanda M" uniqKey="Jamieson A" first="Amanda M" last="Jamieson">Amanda M. Jamieson</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, Brown University, Providence, RI, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Brown University, Providence, RI</wicri:regionArea>
<placeName><region type="state">Rhode Island</region>
<settlement type="city">Providence (Rhode Island)</settlement>
</placeName>
<orgName type="university">Université Brown</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:32201496</idno>
<idno type="pmid">32201496</idno>
<idno type="doi">10.2217/fvl-2016-0060</idno>
<idno type="wicri:Area/PubMed/Corpus">000C32</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C32</idno>
<idno type="wicri:Area/PubMed/Curation">000C32</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C32</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000C45</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C45</idno>
<idno type="wicri:Area/Ncbi/Merge">003477</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Host resilience to emerging coronaviruses.</title>
<author><name sortKey="Jamieson, Amanda M" sort="Jamieson, Amanda M" uniqKey="Jamieson A" first="Amanda M" last="Jamieson">Amanda M. Jamieson</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, Brown University, Providence, RI, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Brown University, Providence, RI</wicri:regionArea>
<placeName><region type="state">Rhode Island</region>
<settlement type="city">Providence (Rhode Island)</settlement>
</placeName>
<orgName type="university">Université Brown</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Future virology</title>
<idno type="ISSN">1746-0794</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Recently, two coronaviruses, severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, have emerged to cause unusually severe respiratory disease in humans. Currently, there is a lack of effective antiviral treatment options or vaccine available. Given the severity of these outbreaks, and the possibility of additional zoonotic coronaviruses emerging in the near future, the exploration of different treatment strategies is necessary. Disease resilience is the ability of a given host to tolerate an infection, and to return to a state of health. This review focuses on exploring various host resilience mechanisms that could be exploited for treatment of severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome coronavirus and other respiratory viruses that cause acute lung injury and acute respiratory distress syndrome.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32201496</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1746-0794</ISSN>
<JournalIssue CitedMedium="Print"><Volume>11</Volume>
<Issue>7</Issue>
<PubDate><Year>2016</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Future virology</Title>
<ISOAbbreviation>Future Virol</ISOAbbreviation>
</Journal>
<ArticleTitle>Host resilience to emerging coronaviruses.</ArticleTitle>
<Pagination><MedlinePgn>529-534</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2217/fvl-2016-0060</ELocationID>
<Abstract><AbstractText>Recently, two coronaviruses, severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, have emerged to cause unusually severe respiratory disease in humans. Currently, there is a lack of effective antiviral treatment options or vaccine available. Given the severity of these outbreaks, and the possibility of additional zoonotic coronaviruses emerging in the near future, the exploration of different treatment strategies is necessary. Disease resilience is the ability of a given host to tolerate an infection, and to return to a state of health. This review focuses on exploring various host resilience mechanisms that could be exploited for treatment of severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome coronavirus and other respiratory viruses that cause acute lung injury and acute respiratory distress syndrome.</AbstractText>
<CopyrightInformation>© 2016 Future Medicine Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jamieson</LastName>
<ForeName>Amanda M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Brown University, Providence, RI, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>07</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Future Virol</MedlineTA>
<NlmUniqueID>101278124</NlmUniqueID>
<ISSNLinking>1746-0794</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALI</Keyword>
<Keyword MajorTopicYN="N">ARDS</Keyword>
<Keyword MajorTopicYN="N">MERS-CoV</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV</Keyword>
<Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">disease tolerance</Keyword>
<Keyword MajorTopicYN="N">host resilience</Keyword>
<Keyword MajorTopicYN="N">pulmonary</Keyword>
<Keyword MajorTopicYN="N">respiratory infection</Keyword>
<Keyword MajorTopicYN="N">viral pathogenesis</Keyword>
</KeywordList>
<CoiStatement>Financial & competing interests disclosure The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>05</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>06</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32201496</ArticleId>
<ArticleId IdType="doi">10.2217/fvl-2016-0060</ArticleId>
<ArticleId IdType="pmc">PMC7079962</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
        <ReferenceList><Reference><Citation>Clin Microbiol Rev. 2015 Apr;28(2):465-522</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25810418</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Opin Virol. 2016 Feb;16:v-vi</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27044798</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Cell Biol. 2011 Dec 12;195(6):931-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22123830</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2014 Jan;88(1):717-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24131722</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2013 Oct;100(1):286-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24012996</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2015 Dec;21(12):1508-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26552008</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2014 Sep;109:72-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24992731</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Sci Rep. 2015 Dec 03;5:17554</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26631542</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Opin Virol. 2016 Feb;16:70-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26855039</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>JAMA. 2003 Dec 24;290(24):3222-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14693875</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Hosp Infect. 2015 Nov;91(3):188-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26452615</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2013 Dec;100(3):605-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24121034</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2007 Apr 25;361(1):18-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17316733</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Host Microbe. 2016 Feb 10;19(2):181-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26867177</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2016 May 12;90(11):5499-5502</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27030263</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Paediatr Respir Rev. 2015 Jun;16(3):197-202</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26002405</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Biol Toxicol. 2016 Jun;32(3):169-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27095254</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2012 Dec;93(Pt 12):2601-2605</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22956738</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rev Immunol. 2012;30:271-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22224770</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2014 May 20;5(3):e01174-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24846384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2015 Apr;89(7):3659-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25589660</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trop Med Int Health. 2004 Aug;9(8):923-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15303999</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Microbes Infect. 2015 May;4(5):e28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26060601</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Virol. 2004 Jan;29(1):13-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14675864</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Future Virol. 2009 Jan 1;4(1):71-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19885368</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2015 Oct;122:28-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26192750</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Semin Immunopathol. 2016 Jul;38(4):471-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26965109</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2015 Mar;115:21-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25554382</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Expert Rev Anti Infect Ther. 2012 Mar;10(3):281-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22397561</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2013 Oct;100(1):246-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23994189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Immunol. 2011 Nov;12(11):1045-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21946417</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trends Mol Med. 2003 Aug;9(8):325-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12928032</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2013 Jun 7;340(6137):1230-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23618765</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Expert Rev Vaccines. 2016 Sep;15(9):1123-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26985862</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rev Cell Dev Biol. 2011;27:493-512</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21639799</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Res. 2012 Apr;165(1):112-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22349148</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Death Dis. 2013 Oct 03;4:e835</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24091678</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2013 Mar 14;495(7440):251-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23486063</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2013 Jun;87(12):6604-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23552422</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>CMAJ. 2004 Nov 23;171(11):1349-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15557587</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2013 Apr 30;4(3):e00165-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23631916</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Crit Care Nurs Q. 2016 Apr-Jun;39(2):190-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26919679</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2016 Nov 12;388(10058):2416-2430</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27133972</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Infect Dis. 2016 Apr;45:1-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26875601</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2015 Dec 30;90(6):3253-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26719272</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2010 Jun;84(11):5670-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20335250</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rev Virol. 2015 Nov;2(1):95-117</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26958908</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioorg Med Chem. 2015 Sep 1;23(17):6036-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26190463</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2015 Aug 11;6(4):e01120</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26265720</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS Biol. 2016 Apr 18;14(4):e1002436</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27088359</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2004 Sep;63(3):209-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15451189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2016 May 27;352(6289):aad7993</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27127234</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Trauma Acute Care Surg. 2016 Aug;81(2):236-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27032012</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Front Immunol. 2011 Nov 24;2:65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22566854</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Infect Dis. 2016 Apr 21;16:174</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27097824</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Microbiol Rev. 2006 Oct;19(4):614-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17041137</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2013 Aug 06;4(4):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23919993</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 2005 Oct 10;23(42):4959-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15993989</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2005 Aug;11(8):875-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16007097</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2014 Jan;101:45-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24184128</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Pathog Dis. 2014 Jul;71(2):121-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24585737</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2015 Sep 29;6(5):e01303-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26419878</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Pathol. 2013 Apr;182(4):1286-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23490254</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virol J. 2013 Dec 23;10:359</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24364985</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virol Sin. 2016 Feb;31(1):24-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26920707</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS Pathog. 2011 Oct;7(10):e1002331</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22046132</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virol Sin. 2016 Feb;31(1):12-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26786772</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Infect Control. 2016 May 2;44(5 Suppl):e91-e100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27131142</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Opin Pulm Med. 2016 May;22(3):203-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26989822</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2009 Sep;15(9):1377-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19788804</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2014 Apr;95(Pt 4):874-882</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24443473</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2012 Feb 24;335(6071):936-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22363001</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chest. 2006 Jun;129(6):1441-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16778260</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2013 Sep;13(9):727-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23891403</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Rhode Island</li>
</region>
<settlement><li>Providence (Rhode Island)</li>
</settlement>
<orgName><li>Université Brown</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Rhode Island"><name sortKey="Jamieson, Amanda M" sort="Jamieson, Amanda M" uniqKey="Jamieson A" first="Amanda M" last="Jamieson">Amanda M. Jamieson</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003477 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003477 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:32201496
   |texte=   Host resilience to emerging coronaviruses.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:32201496" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Host resilience to emerging coronaviruses.

Host resilience to emerging coronaviruses.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki